Vogenx

VOGXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$438.522 M

$29.52 +24.82%

Close of 21 Aug 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 503 →

#217KamadaKMDA$475.3M
#218Benitec BiopharmaBNTC$463.1M
#219VogenxVOGX$438.5M
#220Atea PharmaceuticalsAVIR$435.5M
#221BioAge LabsBIOA$435.1M

Where these numbers come from

Share counts and financials for Vogenx are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 21 Aug 2026. Read the methodology.